Yu J, Yu DW, Checkla DM, Freedberg IM, Bertolino AP
GLP-1 Receptor Agonists - Podcast Version GLP-1 (glucagon-like peptide-1) receptor agonists are injectable medicines used for the treatment of type 2 diabetes and, more recently, for weight management
Immune support Who it may fit Adults seeking antioxidant support for daily cellular wellness or those interested in supporting natural detoxification processes
What was studied: The incidence of major adverse cardiovascular events Outcome: Semaglutide reduced the relative risk of adverse cardiovascular events by 20%, translating to an absolute reduction of 1.5 percentage points, from 8.0% in placebo participants to 6.5% in semaglutide participants
For example, V 2 O 5 nanozymes with exposed (010) facets exhibit higher GPx-like activity than those with other facets 121